FIELD: medicine.
SUBSTANCE: method refers to medicine, namely to therapy, and concerns the correction of vascular microelement oversaving accompanying atherosclerosis. That is ensured by administering effective amounts of bisphosphonates - either xydiphone, or mediphone, or zoledronate.
EFFECT: method provides reducing the deposition of microaggregated calcium salts and other microelements in the vascular walls accompanying experimental atherosclerosis.
1 dwg, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ATHEROSCLEROSIS MODELLING | 2013 |
|
RU2545433C1 |
HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
MEDICATION FOR PREVENTION AND TREATMENT OF ATHEROSLEROSIS | 2011 |
|
RU2468789C1 |
HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
METHOD FOR SIMULATING ATHEROSCLEROSIS | 2013 |
|
RU2524127C1 |
METHOD OF SIMULATING ATHEROSCLEROSIS | 2012 |
|
RU2500041C1 |
AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
PHARMACEUTICAL COMBINATION OF ATORVASTATIN AND NICERGOLIN FOR PREVENTING OR TREATING CEREBROVASCULAR DISEASE | 2011 |
|
RU2481124C1 |
Authors
Dates
2014-03-27—Published
2012-11-30—Filed